Mitchell Capital Management Co. decreased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 5.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,767 shares of the medical equipment provider’s stock after selling 449 shares during the period. Mitchell Capital Management Co.’s holdings in Intuitive Surgical were worth $4,028,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ISRG. Chilton Capital Management LLC raised its position in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 43 shares during the last quarter. Elite Financial Inc. acquired a new position in Intuitive Surgical during the first quarter worth about $26,000. LFA Lugano Financial Advisors SA acquired a new position in Intuitive Surgical during the first quarter worth about $30,000. TD Capital Management LLC raised its position in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares during the last quarter. Finally, 1248 Management LLC acquired a new position in Intuitive Surgical during the first quarter worth about $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.
Insider Activity at Intuitive Surgical
In related news, Director Amy L. Ladd sold 335 shares of the business’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director directly owned 739 shares in the company, valued at approximately $325,669.91. The trade was a 31.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares of the company’s stock, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
View Our Latest Research Report on ISRG
Intuitive Surgical Price Performance
Shares of NASDAQ ISRG opened at $429.59 on Monday. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The company has a 50-day simple moving average of $458.68 and a 200-day simple moving average of $497.84. The company has a market cap of $154.00 billion, a PE ratio of 59.91, a price-to-earnings-growth ratio of 4.51 and a beta of 1.61.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last released its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same period in the previous year, the firm earned $1.78 earnings per share. Intuitive Surgical’s revenue was up 21.4% compared to the same quarter last year. On average, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- How to Calculate Stock Profit
- Could Target’s Week of Discounts Come Full Circle for Investors?
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.